Skip to content

A real-world multicenter clinical study of perampanel as adjunctive treatment in children with epilepsy in China

A real-world multicenter clinical study of perampanel as adjunctive treatment in children with epilepsy in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074696
Enrollment
Unknown
Registered
2023-08-14
Start date
2021-10-01
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

Perampanel group:N/A

Sponsors

Department of Neurology,Wuhan Children's Hospital of Tongji Medical College,Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: ?age:=4y=12y;?patients should have experienenced =1 seizures per month within 3 months prior to the pretreatment phase;?patients who used 1-3 antiepileptic drugs but failed need to add other antiepileptic treatment.

Exclusion criteria

Exclusion criteria: ?patients who participate other antiepileptic drugs or medical devices clinical studies; ?clinical records were inaccurate or unreliable; ?when the end of the project, the expected follow-up was less than 6 months

Design outcomes

Primary

MeasureTime frame
Seizure frequency;

Secondary

MeasureTime frame
Adverse event incidence rate;Drug retention rate;

Countries

China

Contacts

Public ContactSun Dan

Department of Neurology,Wuhan Children's Hospital of Tongji Medical College,Huazhong Universityof Science and Technology

bloveriver@163.com+86 139 7161 6910

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 28, 2026